<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34565332</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1528-3658</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Sep</Month><Day>26</Day></PubDate></JournalIssue><Title>Molecular medicine (Cambridge, Mass.)</Title><ISOAbbreviation>Mol Med</ISOAbbreviation></Journal><ArticleTitle>Addressing the 'hypoxia paradox' in severe COVID-19: literature review and report of four cases treated with erythropoietin analogues.</ArticleTitle><Pagination><StartPage>120</StartPage><MedlinePgn>120</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">120</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s10020-021-00381-5</ELocationID><Abstract><AbstractText Label="BACKGROUND">Since fall 2019, SARS-CoV-2 spread world-wide, causing a major pandemic with estimated ~&#x2009;220&#xa0;million subjects affected as of September 2021. Severe COVID-19 is associated with multiple organ failure, particularly of lung and kidney, but also grave neuropsychiatric manifestations. Overall mortality reaches&#x2009;&gt;&#x2009;2%. Vaccine development has thrived in thus far unreached dimensions and will be one prerequisite to terminate the pandemic. Despite intensive research, however, few treatment options for modifying COVID-19 course/outcome have emerged since the pandemic outbreak. Additionally, the substantial threat of serious downstream sequelae, called 'long COVID' and 'neuroCOVID', becomes increasingly evident. Among candidates that were suggested but did not yet receive appropriate funding for clinical trials is recombinant human erythropoietin. Based on accumulating experimental and clinical evidence, erythropoietin is expected to (1) improve respiration/organ function, (2) counteract overshooting inflammation, (3) act sustainably neuroprotective/neuroregenerative. Recent counterintuitive findings of decreased serum erythropoietin levels in severe COVID-19 not only support a relative deficiency of erythropoietin in this condition, which can be therapeutically addressed, but also made us coin the term 'hypoxia paradox'. As we review here, this paradox is likely due to uncoupling of physiological hypoxia signaling circuits, mediated by detrimental gene products of SARS-CoV-2 or unfavorable host responses, including microRNAs or dysfunctional mitochondria. Substitution of erythropoietin might overcome this 'hypoxia paradox' caused by deranged signaling and improve survival/functional status of COVID-19 patients and their long-term outcome. As supporting hints, embedded in this review, we present 4 male patients with severe COVID-19 and unfavorable prognosis, including predicted high lethality, who all profoundly improved upon treatment which included erythropoietin analogues.</AbstractText><AbstractText Label="SHORT CONCLUSION">Substitution of EPO may-among other beneficial EPO effects in severe COVID-19-circumvent downstream consequences of the 'hypoxia paradox'. A double-blind, placebo-controlled, randomized clinical trial for proof-of-concept is warranted.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Begemann</LastName><ForeName>Martin</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-0493-7370</Identifier><AffiliationInfo><Affiliation>Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Hermann-Rein-Str.3, 37075, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, University Medical Center, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Gross</LastName><ForeName>Oliver</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0002-8390-8852</Identifier><AffiliationInfo><Affiliation>Department of Nephrology and Rheumatology, University Medical Center, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wincewicz</LastName><ForeName>Dominik</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-0747-6306</Identifier><AffiliationInfo><Affiliation>Hospital Clinic, Institute of Neuroscience, IDIBAPS, CIBERSAM, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hardeland</LastName><ForeName>R&#xfc;diger</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-0178-6378</Identifier><AffiliationInfo><Affiliation>Johann Friedrich Blumenbach Institute of Zoology &amp; Anthropology, University of G&#xf6;ttingen, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daguano Gastaldi</LastName><ForeName>Vinicius</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-6249-6035</Identifier><AffiliationInfo><Affiliation>Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Hermann-Rein-Str.3, 37075, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vieta</LastName><ForeName>Eduard</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-0548-0053</Identifier><AffiliationInfo><Affiliation>Hospital Clinic, Institute of Neuroscience, IDIBAPS, CIBERSAM, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weissenborn</LastName><ForeName>Karin</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-1157-8938</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miskowiak</LastName><ForeName>Kamilla W</ForeName><Initials>KW</Initials><Identifier Source="ORCID">0000-0003-2572-1384</Identifier><AffiliationInfo><Affiliation>Psychiatric Centre Copenhagen, University Hospital, Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moerer</LastName><ForeName>Onnen</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0002-4210-388X</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesiology, University Medical Center G&#xf6;ttingen, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ehrenreich</LastName><ForeName>Hannelore</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-8371-5711</Identifier><AffiliationInfo><Affiliation>Clinical Neuroscience, Max Planck Institute of Experimental Medicine, Hermann-Rein-Str.3, 37075, G&#xf6;ttingen, Germany. ehrenreich@em.mpg.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>TRR 274/1 2020 - 408885537</GrantID><Agency>dfg</Agency><Country/></Grant><Grant><GrantID>R215-2015-4121</GrantID><Agency>lundbeckfonden</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Mol Med</MedlineTA><NlmUniqueID>9501023</NlmUniqueID><ISSNLinking>1076-1551</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C554270">EPO protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>11096-26-7</RegistryNumber><NameOfSubstance UI="D004921">Erythropoietin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004921" MajorTopicYN="N">Erythropoietin</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000860" MajorTopicYN="N">Hypoxia</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000093485" MajorTopicYN="Y">COVID-19 Drug Treatment</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Critical care</Keyword><Keyword MajorTopicYN="N">Darbepoetin</Keyword><Keyword MajorTopicYN="N">Neuroprotection</Keyword><Keyword MajorTopicYN="N">Outcome</Keyword><Keyword MajorTopicYN="N">Recombinant human EPO</Keyword><Keyword MajorTopicYN="N">Signaling</Keyword><Keyword MajorTopicYN="N">Treatment</Keyword></KeywordList><CoiStatement>Authors report no conflict of interest related to this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>27</Day><Hour>5</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>9</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34565332</ArticleId><ArticleId IdType="pmc">PMC8474703</ArticleId><ArticleId IdType="doi">10.1186/s10020-021-00381-5</ArticleId><ArticleId IdType="pii">10.1186/s10020-021-00381-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Al-Ramadan A, Rabab'h O, Shah J, Gharaibeh A. Acute and post-acute neurological complications of COVID-19. Neurol Int. 2021;13:102&#x2013;119. doi: 10.3390/neurolint13010010.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/neurolint13010010</ArticleId><ArticleId IdType="pmc">PMC8006051</ArticleId><ArticleId IdType="pubmed">33803475</ArticleId></ArticleIdList></Reference><Reference><Citation>Arias-Reyes C, Zubieta-Deurioste N, Poma-Machicao L, Aliaga-Raduan F, Carvajal-Rodriguez F, Dutschmann M, et al. Does the pathogenesis of SARS-CoV-2 virus decrease at high-altitude? Respir Physiol Neurobiol. 2020;277:103443. doi: 10.1016/j.resp.2020.103443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resp.2020.103443</ArticleId><ArticleId IdType="pmc">PMC7175867</ArticleId><ArticleId IdType="pubmed">32333993</ArticleId></ArticleIdList></Reference><Reference><Citation>Arias-Reyes C, Carvajal-Rodriguez F, Poma-Machicao L, Aliaga-Raduan F, Marques DA, Zubieta-Deurioste N, et al. Decreased incidence, virus transmission capacity, and severity of COVID-19 at altitude on the American continent. PLoS ONE. 2021;16:e0237294. doi: 10.1371/journal.pone.0237294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0237294</ArticleId><ArticleId IdType="pmc">PMC8006995</ArticleId><ArticleId IdType="pubmed">33780470</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartels C, Spate K, Krampe H, Ehrenreich H. Recombinant human erythropoietin: novel strategies for neuroprotective/neuro-regenerative treatment of multiple sclerosis. Ther Adv Neurol Disord. 2008;1:193&#x2013;206. doi: 10.1177/1756285608098422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1756285608098422</ArticleId><ArticleId IdType="pmc">PMC3002551</ArticleId><ArticleId IdType="pubmed">21180577</ArticleId></ArticleIdList></Reference><Reference><Citation>Batista C, Shoham S, Ergonul O, Hotez P, Bottazzi ME, Figueroa JP, et al. Urgent needs to accelerate the race for COVID-19 therapeutics. EClinicalMedicine. 2021;36:100911. doi: 10.1016/j.eclinm.2021.100911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100911</ArticleId><ArticleId IdType="pmc">PMC8141354</ArticleId><ArticleId IdType="pubmed">34036254</ArticleId></ArticleIdList></Reference><Reference><Citation>Beall CM. Detecting natural selection in high-altitude human populations. Respir Physiol Neurobiol. 2007;158:161&#x2013;171. doi: 10.1016/j.resp.2007.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resp.2007.05.013</ArticleId><ArticleId IdType="pubmed">17644049</ArticleId></ArticleIdList></Reference><Reference><Citation>Becher T, Frerichs I. Mortality in COVID-19 is not merely a question of resource availability. Lancet Respir Med. 2020;8:832&#x2013;833. doi: 10.1016/s2213-2600(20)30312-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2213-2600(20)30312-x</ArticleId><ArticleId IdType="pmc">PMC7386881</ArticleId><ArticleId IdType="pubmed">32735840</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilaloglu S, Aphinyanaphongs Y, Jones S, Iturrate E, Hochman J, Berger JS. Thrombosis in hospitalized patients with COVID-19 in a New York City health system. JAMA. 2020;324:799&#x2013;801. doi: 10.1001/jama.2020.13372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.13372</ArticleId><ArticleId IdType="pmc">PMC7372509</ArticleId><ArticleId IdType="pubmed">32702090</ArticleId></ArticleIdList></Reference><Reference><Citation>Birhane M, Bressler S, Chang G, Clark T, Dorough L, Fischer M, et al. COVID-19 vaccine breakthrough infections reported to CDC&#x2014;United States, January 1&#x2013;April 30, 2021. MMWR Morb Mortal Wkly Rep. 2021;70:792&#x2013;793. doi: 10.15585/mmwr.mm7021e3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7021e3</ArticleId><ArticleId IdType="pmc">PMC8158893</ArticleId><ArticleId IdType="pubmed">34043615</ArticleId></ArticleIdList></Reference><Reference><Citation>Boldrini M, Canoll PD, Klein RS. How COVID-19 affects the brain. JAMA Psychiat. 2021 doi: 10.1001/jamapsychiatry.2021.0500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2021.0500</ArticleId><ArticleId IdType="pmc">PMC9894299</ArticleId><ArticleId IdType="pubmed">33769431</ArticleId></ArticleIdList></Reference><Reference><Citation>Brines M, Cerami A. Emerging biological roles for erythropoietin in the nervous system. Nat Rev Neurosci. 2005;6:484&#x2013;494. doi: 10.1038/nrn1687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn1687</ArticleId><ArticleId IdType="pubmed">15928718</ArticleId></ArticleIdList></Reference><Reference><Citation>Butt UJ, Steixner-Kumar AA, Depp C, Sun T, Hassouna I, Wustefeld L, et al. Hippocampal neurons respond to brain activity with functional hypoxia. Mol Psychiatry. 2021 doi: 10.1038/s41380-020-00988-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-020-00988-w</ArticleId><ArticleId IdType="pmc">PMC8440186</ArticleId><ArticleId IdType="pubmed">33564132</ArticleId></ArticleIdList></Reference><Reference><Citation>Buzhdygan TP, Deore BJ, Baldwin-Leclair A, Bullock TA, Mcgary HM, Khan JA, et al. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier. Neurobiol Dis. 2020;146:105131. doi: 10.1016/j.nbd.2020.105131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105131</ArticleId><ArticleId IdType="pmc">PMC7547916</ArticleId><ArticleId IdType="pubmed">33053430</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi A, Bernabei R, Landi F, Gemelli Against, C.-P.-a.C.S.G Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Carota G, Ronsisvalle S, Panarello F, Tibullo D, Nicolosi A, Li Volti G. Role of iron chelation and protease inhibition of natural products on COVID-19 infection. J Clin Med. 2021;10:2306. doi: 10.3390/jcm10112306.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10112306</ArticleId><ArticleId IdType="pmc">PMC8198259</ArticleId><ArticleId IdType="pubmed">34070628</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang R, Elhusseiny KM, Yeh YC, Sun WZ. COVID-19 ICU and mechanical ventilation patient characteristics and outcomes-a systematic review and meta-analysis. PLoS ONE. 2021;16:e0246318. doi: 10.1371/journal.pone.0246318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0246318</ArticleId><ArticleId IdType="pmc">PMC7877631</ArticleId><ArticleId IdType="pubmed">33571301</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Wang H, Liang Z, Peng L, Zhao F, Yang L, et al. Predicting illness severity and short-term outcomes of COVID-19: a retrospective cohort study in China. Innovation (n y) 2020;1:100007. doi: 10.1016/j.xinn.2020.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xinn.2020.04.007</ArticleId><ArticleId IdType="pmc">PMC7237911</ArticleId><ArticleId IdType="pubmed">33554186</ArticleId></ArticleIdList></Reference><Reference><Citation>Cluzeau T, Mcgraw KL, Irvine B, Masala E, Ades L, Basiorka AA, et al. Pro-inflammatory proteins S100A9 and tumor necrosis factor-alpha suppress erythropoietin elaboration in myelodysplastic syndromes. Haematologica. 2017;102:2015&#x2013;2020. doi: 10.3324/haematol.2016.158857.</Citation><ArticleIdList><ArticleId IdType="doi">10.3324/haematol.2016.158857</ArticleId><ArticleId IdType="pmc">PMC5709100</ArticleId><ArticleId IdType="pubmed">28983059</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai W, Zhang B, Jiang XM, Su H, Li J, Zhao Y, et al. Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease. Science. 2020;368:1331&#x2013;1335. doi: 10.1126/science.abb4489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb4489</ArticleId><ArticleId IdType="pmc">PMC7179937</ArticleId><ArticleId IdType="pubmed">32321856</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, Mccorkell L, Wei H, Low RJ, Re&#x2019;em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. medRxiv. 2021;2020.2012.2024.20248802. 10.1101/2020.12.24.20248802.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Dotan A, Muller S, Kanduc D, David P, Halpert G, Shoenfeld Y. The SARS-CoV-2 as an instrumental trigger of autoimmunity. Autoimmun Rev. 2021;20:102792. doi: 10.1016/j.autrev.2021.102792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2021.102792</ArticleId><ArticleId IdType="pmc">PMC7892316</ArticleId><ArticleId IdType="pubmed">33610751</ArticleId></ArticleIdList></Reference><Reference><Citation>Edara VV, Norwood C, Floyd K, Lai L, Davis-Gardner ME, Hudson WH, et al. Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant. Cell Host Microbe. 2021;29:516&#x2013;521.e513. doi: 10.1016/j.chom.2021.03.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2021.03.009</ArticleId><ArticleId IdType="pmc">PMC7980225</ArticleId><ArticleId IdType="pubmed">33798491</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrenreich H, Degner D, Meller J, Brines M, Behe M, Hasselblatt M, et al. Erythropoietin: a candidate compound for neuroprotection in schizophrenia. Mol Psychiatry. 2004;9:42&#x2013;54. doi: 10.1038/sj.mp.4001442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.mp.4001442</ArticleId><ArticleId IdType="pubmed">14581931</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrenreich H, Fischer B, Norra C, Schellenberger F, Stender N, Stiefel M, et al. Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis. Brain. 2007;130:2577&#x2013;2588. doi: 10.1093/brain/awm203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awm203</ArticleId><ArticleId IdType="pubmed">17728357</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrenreich H, Hinze-Selch D, Stawicki S, Aust C, Knolle-Veentjer S, Wilms S, et al. Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin. Mol Psychiatry. 2007;12:206&#x2013;220. doi: 10.1038/sj.mp.4001907.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.mp.4001907</ArticleId><ArticleId IdType="pubmed">17033631</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrenreich H, Weissenborn K, Begemann M, Busch M, Vieta E, Miskowiak KW. Erythropoietin as candidate for supportive treatment of severe COVID-19. Mol Med. 2020;26:58. doi: 10.1186/s10020-020-00186-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10020-020-00186-y</ArticleId><ArticleId IdType="pmc">PMC7297268</ArticleId><ArticleId IdType="pubmed">32546125</ArticleId></ArticleIdList></Reference><Reference><Citation>Fajgenbaum DC, June CH. Cytokine storm. N Engl J Med. 2020;383:2255&#x2013;2273. doi: 10.1056/NEJMra2026131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra2026131</ArticleId><ArticleId IdType="pmc">PMC7727315</ArticleId><ArticleId IdType="pubmed">33264547</ArticleId></ArticleIdList></Reference><Reference><Citation>Flynn RA, Belk JA, Qi Y, Yasumoto Y, Wei J, Alfajaro MM, et al. Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions. Cell. 2021;184:2394&#x2013;2411.e2316. doi: 10.1016/j.cell.2021.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.03.012</ArticleId><ArticleId IdType="pmc">PMC7951565</ArticleId><ArticleId IdType="pubmed">33743211</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Beltran WF, Lam EC, St Denis K, Nitido AD, Garcia ZH, Hauser BM, et al. Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity. Cell. 2021;184:2372&#x2013;2383.e2379. doi: 10.1016/j.cell.2021.03.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.03.013</ArticleId><ArticleId IdType="pmc">PMC7953441</ArticleId><ArticleId IdType="pubmed">33743213</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, White KM, et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. 2020;583:459&#x2013;468. doi: 10.1038/s41586-020-2286-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2286-9</ArticleId><ArticleId IdType="pmc">PMC7431030</ArticleId><ArticleId IdType="pubmed">32353859</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;nther S, Reinke PYA, Fernandez-Garcia Y, Lieske J, Lane TJ, Ginn HM, et al. X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease. Science. 2021;372:642&#x2013;646. doi: 10.1126/science.abf7945.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abf7945</ArticleId><ArticleId IdType="pmc">PMC8224385</ArticleId><ArticleId IdType="pubmed">33811162</ArticleId></ArticleIdList></Reference><Reference><Citation>Haas EJ, Angulo FJ, Mclaughlin JM, Anis E, Singer SR, Khan F, et al. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. Lancet. 2021;397:1819&#x2013;1829. doi: 10.1016/S0140-6736(21)00947-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00947-8</ArticleId><ArticleId IdType="pmc">PMC8099315</ArticleId><ArticleId IdType="pubmed">33964222</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadadi A, Mortezazadeh M, Kolahdouzan K, Alavian G. Does recombinant human erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects? J Med Virol. 2020;92:915&#x2013;918. doi: 10.1002/jmv.25839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25839</ArticleId><ArticleId IdType="pmc">PMC7262240</ArticleId><ArticleId IdType="pubmed">32270515</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpert G, Shoenfeld Y. SARS-CoV-2, the autoimmune virus. Autoimmun Rev. 2020;19:102695. doi: 10.1016/j.autrev.2020.102695.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102695</ArticleId><ArticleId IdType="pmc">PMC7598743</ArticleId><ArticleId IdType="pubmed">33130000</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammer C, Stepniak B, Schneider A, Papiol S, Tantra M, Begemann M, et al. Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity. Mol Psychiatry. 2014;19:1143&#x2013;1149. doi: 10.1038/mp.2013.110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2013.110</ArticleId><ArticleId IdType="pubmed">23999527</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang CL, Huang LX, Wang YM, Li X, Ren LL, Gu XY, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal FM, Lam K, Sounderajah V, Clarke JM, Ashrafian H, Darzi A. Characteristics and predictors of acute and chronic post-COVID syndrome: a systematic review and meta-analysis. EClinicalMedicine. 2021;36:100899. doi: 10.1016/j.eclinm.2021.100899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100899</ArticleId><ArticleId IdType="pmc">PMC8141371</ArticleId><ArticleId IdType="pubmed">34036253</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakhmola S, Indari O, Kashyap D, Varshney N, Das A, Manivannan E, et al. Mutational analysis of structural proteins of SARS-CoV-2. Heliyon. 2021;7:e06572. doi: 10.1016/j.heliyon.2021.e06572.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2021.e06572</ArticleId><ArticleId IdType="pmc">PMC7980187</ArticleId><ArticleId IdType="pubmed">33778179</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaramillo PRM, Simba&#xf1;a-Rivera K, Silva JVV, G&#xf3;mez-Barreno L, Campoverde ABV, Cevallos JFN, et al. High-altitude is associated with better short-term survival in critically ill COVID-19 patients admitted to the ICU. medRxiv. 2021;2021.2001.2022.21249811. 10.1101/2021.01.22.21249811.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8970356</ArticleId><ArticleId IdType="pubmed">35358185</ArticleId></ArticleIdList></Reference><Reference><Citation>Jelkmann W. Erythropoietin: structure, control of production, and function. Physiol Rev. 1992;72:449&#x2013;489. doi: 10.1152/physrev.1992.72.2.449.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.1992.72.2.449</ArticleId><ArticleId IdType="pubmed">1557429</ArticleId></ArticleIdList></Reference><Reference><Citation>Karagiannidis C, Mostert C, Hentschker C, Voshaar T, Malzahn J, Schillinger G, et al. Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study. Lancet Respir Med. 2020;8:853&#x2013;862. doi: 10.1016/s2213-2600(20)30316-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2213-2600(20)30316-7</ArticleId><ArticleId IdType="pmc">PMC7386882</ArticleId><ArticleId IdType="pubmed">32735842</ArticleId></ArticleIdList></Reference><Reference><Citation>Karagiannidis C, Windisch W, Mcauley DF, Welte T, Busse R. Major differences in ICU admissions during the first and second COVID-19 wave in Germany. Lancet Respir Med. 2021;9:e47&#x2013;e48. doi: 10.1016/S2213-2600(21)00101-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00101-6</ArticleId><ArticleId IdType="pmc">PMC8078895</ArticleId><ArticleId IdType="pubmed">33684356</ArticleId></ArticleIdList></Reference><Reference><Citation>Kihira S, Morgenstern PF, Raynes H, Naidich TP, Belani P. Fatal cerebral infarct in a child with COVID-19. Pediatr Radiol. 2020;50:1479&#x2013;1480. doi: 10.1007/s00247-020-04779-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00247-020-04779-x</ArticleId><ArticleId IdType="pmc">PMC7376273</ArticleId><ArticleId IdType="pubmed">32705305</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim PS, Read SW, Fauci AS. Therapy for early COVID-19: a critical need. JAMA. 2020;324:2149&#x2013;2150. doi: 10.1001/jama.2020.22813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.22813</ArticleId><ArticleId IdType="pubmed">33175121</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok FA, Kruip M, Van Der Meer NJM, Arbous MS, Gommers D, Kant KM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145&#x2013;147. doi: 10.1016/j.thromres.2020.04.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.04.013</ArticleId><ArticleId IdType="pmc">PMC7146714</ArticleId><ArticleId IdType="pubmed">32291094</ArticleId></ArticleIdList></Reference><Reference><Citation>Kluge S, Janssens U, Spinner CD, Pfeifer M, Marx G, Karagiannidis C, et al. Clinical practice guideline: recommendations on inpatient treatment of patients with COVID-19. Dtsch Arztebl Int. 2021 doi: 10.3238/arztebl.m2021.0110.</Citation><ArticleIdList><ArticleId IdType="doi">10.3238/arztebl.m2021.0110</ArticleId><ArticleId IdType="pmc">PMC8119662</ArticleId><ArticleId IdType="pubmed">33531113</ArticleId></ArticleIdList></Reference><Reference><Citation>Krantz SB. Erythropoietin. Blood. 1991;77:419&#x2013;434. doi: 10.1182/blood.V77.3.419.419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V77.3.419.419</ArticleId><ArticleId IdType="pubmed">1991159</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo CL, Pilling LC, Atkins JL, Masoli JAH, Delgado J, Kuchel GA, et al. APOE e4 genotype predicts severe COVID-19 in the UK biobank community cohort. J Gerontol A Biol Sci Med Sci. 2020;75:2231&#x2013;2232. doi: 10.1093/gerona/glaa131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/glaa131</ArticleId><ArticleId IdType="pmc">PMC7314139</ArticleId><ArticleId IdType="pubmed">32451547</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwack C, Balakrishnan VS. Managing erythropoietin hyporesponsiveness. Semin Dial. 2006;19:146&#x2013;151. doi: 10.1111/j.1525-139X.2006.00141.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1525-139X.2006.00141.x</ArticleId><ArticleId IdType="pubmed">16551293</ArticleId></ArticleIdList></Reference><Reference><Citation>Larovere KL, Riggs BJ, Poussaint TY, Young CC, Newhams MM, Maamari M, et al. Neurologic involvement in children and adolescents hospitalized in the United States for COVID-19 or multisystem inflammatory syndrome. JAMA Neurol. 2021;78:536&#x2013;547. doi: 10.1001/jamaneurol.2021.0504.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2021.0504</ArticleId><ArticleId IdType="pmc">PMC7936352</ArticleId><ArticleId IdType="pubmed">33666649</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MH, Perl DP, Nair G, Li W, Maric D, Murray H, et al. Microvascular injury in the brains of patients with Covid-19. N Engl J Med. 2021;384:481&#x2013;483. doi: 10.1056/NEJMc2033369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2033369</ArticleId><ArticleId IdType="pmc">PMC7787217</ArticleId><ArticleId IdType="pubmed">33378608</ArticleId></ArticleIdList></Reference><Reference><Citation>Leventhal J, Angeletti A, Cravedi P. EPO in patients with COVID-19: more than an erythropoietic hormone. Am J Kidney Dis. 2020;76:441. doi: 10.1053/j.ajkd.2020.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2020.06.002</ArticleId><ArticleId IdType="pmc">PMC7834670</ArticleId><ArticleId IdType="pubmed">32534130</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020;7:e438&#x2013;e440. doi: 10.1016/S2352-3026(20)30145-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(20)30145-9</ArticleId><ArticleId IdType="pmc">PMC7213964</ArticleId><ArticleId IdType="pubmed">32407672</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T, Huang T, Guo C, Wang A, Shi X, Mo X, et al. Genomic variation, origin tracing, and vaccine development of SARS-CoV-2: a systematic review. Innovation (n y) 2021;2:100116. doi: 10.1016/j.xinn.2021.100116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xinn.2021.100116</ArticleId><ArticleId IdType="pmc">PMC8110321</ArticleId><ArticleId IdType="pubmed">33997827</ArticleId></ArticleIdList></Reference><Reference><Citation>Litton E, Latham P, Inman J, Luo J, Allan P. Safety and efficacy of erythropoiesis-stimulating agents in critically ill patients admitted to the intensive care unit: a systematic review and meta-analysis. Intensive Care Med. 2019;45:1190&#x2013;1199. doi: 10.1007/s00134-019-05686-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-019-05686-y</ArticleId><ArticleId IdType="pubmed">31297547</ArticleId></ArticleIdList></Reference><Reference><Citation>Llach CD, Vieta E. Mind long COVID: psychiatric sequelae of SARS-CoV-2 infection. Eur Neuropsychopharmacol. 2021;49:119&#x2013;121. doi: 10.1016/j.euroneuro.2021.04.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euroneuro.2021.04.019</ArticleId><ArticleId IdType="pmc">PMC8098059</ArticleId><ArticleId IdType="pubmed">33992951</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395:565&#x2013;574. doi: 10.1016/S0140-6736(20)30251-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30251-8</ArticleId><ArticleId IdType="pmc">PMC7159086</ArticleId><ArticleId IdType="pubmed">32007145</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:683&#x2013;690. doi: 10.1001/jamaneurol.2020.1127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Masoli J, Kuo CL, Atkins J, Pilling L, Delgado J, Kuchel G, et al. 38 Dementia, Apoe and COVID-19 severity. Age Ageing. 2021;50:i7&#x2013;i11. doi: 10.1093/ageing/afab029.17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afab029.17</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J, Lutgehetmann M, Hagel C, Sperhake JP, Schroder AS, Edler C, et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 2020;19:919&#x2013;929. doi: 10.1016/S1474-4422(20)30308-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30308-2</ArticleId><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P, Mcauley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033&#x2013;1034. doi: 10.1016/S0140-6736(20)30628-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30628-0</ArticleId><ArticleId IdType="pmc">PMC7270045</ArticleId><ArticleId IdType="pubmed">32192578</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J, Radke J, Dittmayer C, Franz J, Thomas C, Mothes R, et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci. 2021;24:168&#x2013;175. doi: 10.1038/s41593-020-00758-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00758-5</ArticleId><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesgarpour B, Heidinger BH, Roth D, Schmitz S, Walsh CD, Herkner H. Harms of off-label erythropoiesis-stimulating agents for critically ill people. Cochrane Database Syst Rev. 2017;8:CD010969. doi: 10.1002/14651858.CD010969.pub2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD010969.pub2</ArticleId><ArticleId IdType="pmc">PMC6373621</ArticleId><ArticleId IdType="pubmed">28841235</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller B, Silverstein A, Flores M, Cao K, Kumagai H, Mehta HH, et al. Host mitochondrial transcriptome response to SARS-CoV-2 in multiple cell models and clinical samples. Sci Rep. 2021;11:3. doi: 10.1038/s41598-020-79552-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-79552-z</ArticleId><ArticleId IdType="pmc">PMC7794290</ArticleId><ArticleId IdType="pubmed">33420163</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskowiak KW, Ehrenreich H, Christensen EM, Kessing LV, Vinberg M. Recombinant human erythropoietin to target cognitive dysfunction in bipolar disorder: a double-blind, randomized, placebo-controlled phase 2 trial. J Clin Psychiatry. 2014;75:1347&#x2013;1355. doi: 10.4088/JCP.13m08839.</Citation><ArticleIdList><ArticleId IdType="doi">10.4088/JCP.13m08839</ArticleId><ArticleId IdType="pubmed">25099079</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskowiak KW, Vinberg M, Christensen EM, Bukh JD, Harmer CJ, Ehrenreich H, et al. Recombinant human erythropoietin for treating treatment-resistant depression: a double-blind, randomized, placebo-controlled phase 2 trial. Neuropsychopharmacology. 2014;39:1399&#x2013;1408. doi: 10.1038/npp.2013.335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/npp.2013.335</ArticleId><ArticleId IdType="pmc">PMC3988543</ArticleId><ArticleId IdType="pubmed">24322509</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskowiak KW, Vinberg M, Macoveanu J, Ehrenreich H, Koster N, Inkster B, et al. Effects of erythropoietin on hippocampal volume and memory in mood disorders. Biol Psychiatry. 2015;78:270&#x2013;277. doi: 10.1016/j.biopsych.2014.12.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2014.12.013</ArticleId><ArticleId IdType="pubmed">25641635</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskowiak KW, Johnsen S, Sattler SM, Nielsen S, Kunalan K, Rungby J, et al. Cognitive impairments four months after COVID-19 hospital discharge: pattern, severity and association with illness variables. Eur Neuropsychopharmacol. 2021;46:39&#x2013;48. doi: 10.1016/j.euroneuro.2021.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euroneuro.2021.03.019</ArticleId><ArticleId IdType="pmc">PMC8006192</ArticleId><ArticleId IdType="pubmed">33823427</ArticleId></ArticleIdList></Reference><Reference><Citation>Montagne A, Nation DA, Sagare AP, Barisano G, Sweeney MD, Chakhoyan A, et al. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. Nature. 2020;581:71&#x2013;76. doi: 10.1038/s41586-020-2247-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2247-3</ArticleId><ArticleId IdType="pmc">PMC7250000</ArticleId><ArticleId IdType="pubmed">32376954</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science. 2020;368:473&#x2013;474. doi: 10.1126/science.abb8925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb8925</ArticleId><ArticleId IdType="pubmed">32303591</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, Mcgroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Nie X, Qian L, Sun R, Huang B, Dong X, Xiao Q, et al. Multi-organ proteomic landscape of COVID-19 autopsies. Cell. 2021;184:775&#x2013;791.e714. doi: 10.1016/j.cell.2021.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.01.004</ArticleId><ArticleId IdType="pmc">PMC7794601</ArticleId><ArticleId IdType="pubmed">33503446</ArticleId></ArticleIdList></Reference><Reference><Citation>Osipiuk J, Azizi SA, Dvorkin S, Endres M, Jedrzejczak R, Jones KA, et al. Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors. Nat Commun. 2021;12:743. doi: 10.1038/s41467-021-21060-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21060-3</ArticleId><ArticleId IdType="pmc">PMC7854729</ArticleId><ArticleId IdType="pubmed">33531496</ArticleId></ArticleIdList></Reference><Reference><Citation>Oxley TJ, Mocco J, Majidi S, Kellner CP, Shoirah H, Singh IP, et al. Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med. 2020;382:e60. doi: 10.1056/NEJMc2009787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2009787</ArticleId><ArticleId IdType="pmc">PMC7207073</ArticleId><ArticleId IdType="pubmed">32343504</ArticleId></ArticleIdList></Reference><Reference><Citation>Paterson RW, Brown RL, Benjamin L, Nortley R, Wiethoff S, Bharucha T, et al. The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain. 2020;143:3104&#x2013;3120. doi: 10.1093/brain/awaa240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa240</ArticleId><ArticleId IdType="pmc">PMC7454352</ArticleId><ArticleId IdType="pubmed">32637987</ArticleId></ArticleIdList></Reference><Reference><Citation>Plante JA, Mitchell BM, Plante KS, Debbink K, Weaver SC, Menachery VD. The variant gambit: COVID-19's next move. Cell Host Microbe. 2021;29:508&#x2013;515. doi: 10.1016/j.chom.2021.02.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2021.02.020</ArticleId><ArticleId IdType="pmc">PMC7919536</ArticleId><ArticleId IdType="pubmed">33789086</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevost J, Finzi A. The great escape? SARS-CoV-2 variants evading neutralizing responses. Cell Host Microbe. 2021;29:322&#x2013;324. doi: 10.1016/j.chom.2021.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2021.02.010</ArticleId><ArticleId IdType="pmc">PMC7945862</ArticleId><ArticleId IdType="pubmed">33705702</ArticleId></ArticleIdList></Reference><Reference><Citation>Puelles VG, Lutgehetmann M, Lindenmeyer MT, Sperhake JP, Wong MN, Allweiss L, et al. Multiorgan and renal tropism of SARS-CoV-2. N Engl J Med. 2020;383:590&#x2013;592. doi: 10.1056/NEJMc2011400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2011400</ArticleId><ArticleId IdType="pmc">PMC7240771</ArticleId><ArticleId IdType="pubmed">32402155</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhea EM, Logsdon AF, Hansen KM, Williams LM, Reed MJ, Baumann KK, et al. The S1 protein of SARS-CoV-2 crosses the blood-brain barrier in mice. Nat Neurosci. 2021;24:368&#x2013;378. doi: 10.1038/s41593-020-00771-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00771-8</ArticleId><ArticleId IdType="pmc">PMC8793077</ArticleId><ArticleId IdType="pubmed">33328624</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivkin M, Simerzin A, Zorde-Khvalevsky E, Chai C, Yuval JB, Rosenberg N, et al. Inflammation-induced expression and secretion of microRNA 122 leads to reduced blood levels of kidney-derived erythropoietin and anemia. Gastroenterology. 2016;151:999&#x2013;1010.e1013. doi: 10.1053/j.gastro.2016.07.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2016.07.031</ArticleId><ArticleId IdType="pubmed">27477940</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahebnasagh A, Mojtahedzadeh M, Najmeddin F, Najafi A, Safdari M, Rezai Ghaleno H, et al. A perspective on erythropoietin as a potential adjuvant therapy for acute lung injury/acute respiratory distress syndrome in patients with COVID-19. Arch Med Res. 2020;51:631&#x2013;635. doi: 10.1016/j.arcmed.2020.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arcmed.2020.08.002</ArticleId><ArticleId IdType="pmc">PMC7418647</ArticleId><ArticleId IdType="pubmed">32863034</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahin U, Muik A, Vogler I, Derhovanessian E, Kranz LM, Vormehr M, et al. BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans. Nature. 2021 doi: 10.1038/s41586-021-03653-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03653-6</ArticleId><ArticleId IdType="pubmed">34044428</ArticleId></ArticleIdList></Reference><Reference><Citation>Sargin D, Friedrichs H, El-Kordi A, Ehrenreich H. Erythropoietin as neuroprotective and neuroregenerative treatment strategy: comprehensive overview of 12 years of preclinical and clinical research. Best Pract Res Clin Anaesthesiol. 2010;24:573&#x2013;594. doi: 10.1016/j.bpa.2010.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpa.2010.10.005</ArticleId><ArticleId IdType="pubmed">21619868</ArticleId></ArticleIdList></Reference><Reference><Citation>Severe Covid-19 Gwas Group Genomewide association study of severe covid-19 with respiratory failure. N Engl J Med. 2020;383:1522&#x2013;1534. doi: 10.1056/NEJMoa2020283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2020283</ArticleId><ArticleId IdType="pmc">PMC7315890</ArticleId><ArticleId IdType="pubmed">32558485</ArticleId></ArticleIdList></Reference><Reference><Citation>Shenoy S. Coronavirus (Covid-19) sepsis: revisiting mitochondrial dysfunction in pathogenesis, aging, inflammation, and mortality. Inflamm Res. 2020;69:1077&#x2013;1085. doi: 10.1007/s00011-020-01389-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-020-01389-z</ArticleId><ArticleId IdType="pmc">PMC7410962</ArticleId><ArticleId IdType="pubmed">32767095</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh KK, Chaubey G, Chen JY, Suravajhala P. Decoding SARS-CoV-2 hijacking of host mitochondria in COVID-19 pathogenesis. Am J Physiol Cell Physiol. 2020;319:C258&#x2013;C267. doi: 10.1152/ajpcell.00224.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00224.2020</ArticleId><ArticleId IdType="pmc">PMC7381712</ArticleId><ArticleId IdType="pubmed">32510973</ArticleId></ArticleIdList></Reference><Reference><Citation>Sir&#xe9;n AL, Fasshauer T, Bartels C, Ehrenreich H. Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system. Neurotherapeutics. 2009;6:108&#x2013;127. doi: 10.1016/j.nurt.2008.10.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nurt.2008.10.041</ArticleId><ArticleId IdType="pmc">PMC5084260</ArticleId><ArticleId IdType="pubmed">19110203</ArticleId></ArticleIdList></Reference><Reference><Citation>Soliz J, Schneider-Gasser EM, Arias-Reyes C, Aliaga-Raduan F, Poma-Machicao L, Zubieta-Calleja G, et al. Coping with hypoxemia: could erythropoietin (EPO) be an adjuvant treatment of COVID-19? Respir Physiol Neurobiol. 2020;279:103476. doi: 10.1016/j.resp.2020.103476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resp.2020.103476</ArticleId><ArticleId IdType="pmc">PMC7275159</ArticleId><ArticleId IdType="pubmed">32522574</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T. Neurological infection with SARS-CoV-2&#x2014;the story so far. Nat Rev Neurol. 2021;17:65&#x2013;66. doi: 10.1038/s41582-020-00453-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-00453-w</ArticleId><ArticleId IdType="pmc">PMC7789883</ArticleId><ArticleId IdType="pubmed">33414554</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon IH, Normandin E, Bhattacharyya S, Mukerji SS, Keller K, Ali AS, et al. Neuropathological features of Covid-19. N Engl J Med. 2020;383:989&#x2013;992. doi: 10.1056/NEJMc2019373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2019373</ArticleId><ArticleId IdType="pmc">PMC7304421</ArticleId><ArticleId IdType="pubmed">32530583</ArticleId></ArticleIdList></Reference><Reference><Citation>Speranza E, Williamson BN, Feldmann F, Sturdevant GL, Perez-Perez L, Meade-White K, et al. Single-cell RNA sequencing reveals SARS-CoV-2 infection dynamics in lungs of African green monkeys. Sci Transl Med. 2021 doi: 10.1126/scitranslmed.abe8146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abe8146</ArticleId><ArticleId IdType="pmc">PMC7875333</ArticleId><ArticleId IdType="pubmed">33431511</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID. Nat Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan L, Kang X, Ji X, Li G, Wang Q, Li Y, et al. Validation of predictors of disease severity and outcomes in COVID-19 patients: a descriptive and retrospective study. Med (n y) 2020;1:128&#x2013;138.e123. doi: 10.1016/j.medj.2020.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2020.05.002</ArticleId><ArticleId IdType="pmc">PMC7235581</ArticleId><ArticleId IdType="pubmed">32838352</ArticleId></ArticleIdList></Reference><Reference><Citation>Taneri PE, Gomez-Ochoa SA, Llanaj E, Raguindin PF, Rojas LZ, Roa-Diaz ZM, et al. Anemia and iron metabolism in COVID-19: a systematic review and meta-analysis. Eur J Epidemiol. 2020;35:763&#x2013;773. doi: 10.1007/s10654-020-00678-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-020-00678-5</ArticleId><ArticleId IdType="pmc">PMC7438401</ArticleId><ArticleId IdType="pubmed">32816244</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416&#x2013;427. doi: 10.1016/s2215-0366(21)00084-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson EA, Cascino K, Ordonez AA, Zhou W, Vaghasia A, Hamacher-Brady A, et al. Metabolic programs define dysfunctional immune responses in severe COVID-19 patients. Cell Rep. 2021;34:108863. doi: 10.1016/j.celrep.2021.108863.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.108863</ArticleId><ArticleId IdType="pmc">PMC7908880</ArticleId><ArticleId IdType="pubmed">33691089</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorne LG, Bouhaddou M, Reuschl A-K, Zuliani-Alvarez L, Polacco BJ, Pelin A, et al. Evolution of enhanced innate immune evasion by the SARS-CoV-2 B.1.1.7 UK variant. bioRxiv. 2021;2021.2006.2006.446826. 10.1101/2021.06.06.446826.</Citation></Reference><Reference><Citation>Tormos KV, Chandel NS. Inter-connection between mitochondria and HIFs. J Cell Mol Med. 2010;14:795&#x2013;804. doi: 10.1111/j.1582-4934.2010.01031.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1582-4934.2010.01031.x</ArticleId><ArticleId IdType="pmc">PMC2987233</ArticleId><ArticleId IdType="pubmed">20158574</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Dyer AH, Jones K, Dunne J, Mooney A, Gaffney F, et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS ONE. 2020;15:e0240784. doi: 10.1371/journal.pone.0240784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240784</ArticleId><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Viruez-Soto A, Lopez-Davalos MM, Rada-Barrera G, Merino-Luna A, Molano-Franco D, Tinoco-Solorozano A, et al. Low serum erythropoietin levels are associated with fatal COVID-19 cases at 4,150 meters above sea level. Respir Physiol Neurobiol. 2021 doi: 10.1016/j.resp.2021.103709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resp.2021.103709</ArticleId><ArticleId IdType="pmc">PMC8169280</ArticleId><ArticleId IdType="pubmed">34087493</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakhloo D, Scharkowski F, Curto Y, Javed Butt U, Bansal V, Steixner-Kumar AA, et al. Functional hypoxia drives neuroplasticity and neurogenesis via brain erythropoietin. Nat Commun. 2020;11:1313. doi: 10.1038/s41467-020-15041-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-15041-1</ArticleId><ArticleId IdType="pmc">PMC7062779</ArticleId><ArticleId IdType="pubmed">32152318</ArticleId></ArticleIdList></Reference><Reference><Citation>Wall EC, Wu M, Harvey R, Kelly G, Warchal S, Sawyer C, et al. Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination. Lancet. 2021 doi: 10.1016/S0140-6736(21)01290-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01290-3</ArticleId><ArticleId IdType="pmc">PMC8175044</ArticleId><ArticleId IdType="pubmed">34090624</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang EY, Mao T, Klein J, Dai Y, Huck JD, Jaycox JR, et al. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021 doi: 10.1038/s41586-021-03631-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Webb BJ, Peltan ID, Jensen P, Hoda D, Hunter B, Silver A, et al. Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study. Lancet Rheumatol. 2020;2:e754&#x2013;e763. doi: 10.1016/S2665-9913(20)30343-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(20)30343-X</ArticleId><ArticleId IdType="pmc">PMC7524533</ArticleId><ArticleId IdType="pubmed">33015645</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Solidarity Trial Consortium Repurposed antiviral drugs for Covid-19 - Interim WHO solidarity trial results. N Engl J Med. 2021;384:497&#x2013;511. doi: 10.1056/NEJMoa2023184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2023184</ArticleId><ArticleId IdType="pmc">PMC7727327</ArticleId><ArticleId IdType="pubmed">33264556</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson E. RECOVERY trial: the UK covid-19 study resetting expectations for clinical trials. BMJ. 2020;369:m1626. doi: 10.1136/bmj.m1626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1626</ArticleId><ArticleId IdType="pubmed">32345591</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . Therapeutics and COVID-19: living guideline, 31 March 2021. Geneva: World Health Organization; 2021.</Citation></Reference><Reference><Citation>World Health Organization. WHO coronavirus (COVID-19) dashboard. 2021b. https://covid19.who.int/. Accessed 07 Sept 2021.</Citation></Reference><Reference><Citation>W&#xfc;stenberg T, Begemann M, Bartels C, Gefeller O, Stawicki S, Hinze-Selch D, et al. Recombinant human erythropoietin delays loss of gray matter in chronic schizophrenia. Mol Psychiatry. 2011;16:26&#x2013;36, 21. 10.1038/mp.2010.51</Citation><ArticleIdList><ArticleId IdType="pubmed">20479759</ArticleId></ArticleIdList></Reference><Reference><Citation>Yagci S, Serin E, Acicbe O, Zeren MI, Odabasi MS. The relationship between serum erythropoietin, hepcidin, and haptoglobin levels with disease severity and other biochemical values in patients with COVID-19. Int J Lab Hematol. 2021 doi: 10.1111/ijlh.13479.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijlh.13479</ArticleId><ArticleId IdType="pmc">PMC8014125</ArticleId><ArticleId IdType="pubmed">33554466</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang AC, Kern F, Losada PM, Agam MR, Maat CA, Schmartz GP, et al. Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature. 2021 doi: 10.1038/s41586-021-03710-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03710-0</ArticleId><ArticleId IdType="pmc">PMC8400927</ArticleId><ArticleId IdType="pubmed">34153974</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan S, Peng L, Park JJ, Hu Y, Devarkar SC, Dong MB, et al. Nonstructural protein 1 of SARS-CoV-2 is a potent pathogenicity factor redirecting host protein synthesis machinery toward viral RNA. Mol Cell. 2020;80:1055&#x2013;1066.e1056. doi: 10.1016/j.molcel.2020.10.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2020.10.034</ArticleId><ArticleId IdType="pmc">PMC7833686</ArticleId><ArticleId IdType="pubmed">33188728</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, et al. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved alpha-ketoamide inhibitors. Science. 2020;368:409&#x2013;412. doi: 10.1126/science.abb3405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb3405</ArticleId><ArticleId IdType="pmc">PMC7164518</ArticleId><ArticleId IdType="pubmed">32198291</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270&#x2013;273. doi: 10.1038/s41586-020-2012-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2012-7</ArticleId><ArticleId IdType="pmc">PMC7095418</ArticleId><ArticleId IdType="pubmed">32015507</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou D, Dejnirattisai W, Supasa P, Liu C, Mentzer AJ, Ginn HM, et al. Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera. Cell. 2021;184:2348&#x2013;2361.e2346. doi: 10.1016/j.cell.2021.02.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.02.037</ArticleId><ArticleId IdType="pmc">PMC7901269</ArticleId><ArticleId IdType="pubmed">33730597</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727&#x2013;733. doi: 10.1056/NEJMoa2001017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001017</ArticleId><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubieta-Calleja G, Zubieta-Deurioste N, Venkatesh T, Das KK, Soliz J. COVID-19 and pneumolysis simulating extreme high-altitude exposure with altered oxygen transport physiology; multiple diseases, and scarce need of ventilators: andean Condor's-eye-view. Rev Recent Clin Trials. 2020;15:347&#x2013;359. doi: 10.2174/1574887115666200925141108.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1574887115666200925141108</ArticleId><ArticleId IdType="pubmed">32981508</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>